Repurposed Drugs and Metabolic Therapy for the Treatment of Cancer
The system won’t tell you the truth. We will.
They said cancer begins in your genes—that mutations cause the chaos. They built an entire industry around that story. And patients kept getting sicker, and treatments kept missing the mark. But now… you’re starting to ask the right questions.
This matters more than you’ve been told. And you're not alone.
What You’ll Learn:
In this urgent GoldCare Webinar, three frontline experts expose what mainstream medicine refuses to face.
Why the somatic mutation theory of cancer no longer fits the evidence
How cellular metabolism may be the true driver of tumor growth
The growing body of data behind repurposed drugs and metabolic therapies
What this shift could mean for treatment, survival, and prevention
Speaker
Dr. Paul Marik
With over 400 peer-reviewed publications and a global reputation for medical innovation, Dr. Paul Marik has spent decades challenging broken paradigms in critical care and beyond. His groundbreaking research into metabolic disease and cancer therapy reframes how we understand—and fight—the world’s most feared illness. In this webinar, Dr. Marik introduces the metabolic model of cancer and explores the overlooked role of repurposed drugs in restoring the body’s natural balance.
You’ve been ignored.
Now it’s time to be heard.
If you or someone you love has faced cancer—or fears its return—this is the truth they hoped you’d never question.
Seats are limited. Truth is not.
Date:
Tuesday, November 4
Time:
8 PM ET
Online:
Hosted by GoldCare
Trust, Freedom, and Personalized Care
We’re not just a healthcare company. We’re a movement. We shine light on information others hide. Our mission: reclaim integrity in medicine and empower individuals to make informed, free choices with confidence.
Join GoldCare
Thousands already trust us. Members get early access to events like this, plus weekly new shows, medical resources, and a community focused on accountability and wellness.
Become a member today — only $10/month.
